Form D · Pharmaceuticals
Botanix Pharmaceuticals Ltd.
North Perth, Western Australia, C3 · CIK 0001785009
Offering snapshot reported Aug 14, 2019 · SEC filing
- Reported sold
- $20M Offering amount: $20M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Jul 31, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 14, 2019 | Initial | $20,036,949 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.2M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-346560
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Cowen and Company | 7616 |
Source: Form D, filed Aug 14, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Bosch | Director, Executive |
| Matthew Callahan | Director, Executive |
| Vince Ippolito | Director, Executive |
| Stephane Levy | Executive |
| Howie Mc Kibbon | Executive |
| Ric Peterson | Executive |
| Michael Thurn | Director, Executive |
| Robert Towner | Director |
| Stewart Washer | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Level 1, 50 Angove Street
North Perth, Western Australia, C3, 6006
North Perth, Western Australia, C3, 6006